Sun To Tap Daiichi Sankyo To Sell Ranbaxy Drugs In Japan
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo, which sold Ranbaxy Laboratories to Sun Pharmaceutical Industries for $4 billion earlier this year, is about to become re-involved with the company it divested.